USANA HEALTH SCIENCES INC

USNA · XNYS

CIK 896264fmd_0NVRE2ZA28BP0PKV5WMBTH32EFManufacturing · Medicinal Chemicals & Botanical ProductsTemplate: Standard

Coverage: Jan 04, 2009 to Oct 03, 2026, 67 periods

Income Statement · Annual · Millions · USD
Line item	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Total revenues	1,006	1,047	1,189	1,061	1,135	1,186	999	921	855	925
Cost of revenue	180	179	201	188	209	218	194	177	161	201
Gross profit	826	868	989	873	926	969	805	744	693	724
Research and development	9	9	10	10	11	11	12	11	12	11
Selling, general and administrative	234	265	275	268	261	279	262	257	263	337
Total operating expenses	687	735	800	727	749	798	697	651	627	687
Operating income	139	133	188	146	176	170	108	93	66	37
Interest expense	0	0	0	0	1	0	0	0	0	1
Interest and investment income	1	2	4	5	3	3	4	10	11	2
Other non-operating income (expense)	(0)	2	3	4	1	0	1	9	10	4
Income before taxes	139	135	192	150	178	171	109	102	76	42
Income tax expense	39	72	65	50	53	54	39	39	34	30
Net income from continuing operations	100	63	126	101	125	117	69	64	42	11
Net income	100	63	126	101	125	117	69	64	42	11
Net income to common shareholders	100	63	126	101	125	117	69	64	–	–